CHYM insider plans sale of 4,382 common shares

CHYM insider Adam Frankel filed a Form 144 to sell 4,382 shares of common stock through Morgan Stanley Smith Barney LLC, with an aggregate market value of $119,321.86.

Rhea-AI Filing Summary

CHYM insider Adam Frankel filed a Form 144 to sell 4,382 shares of common stock through Morgan Stanley Smith Barney LLC, with an aggregate market value of $119,321.86. The shares relate to restricted stock units acquired from the issuer on 06/12/2025, and the planned sale is approximately dated 01/08/2026 on the NASDAQ. The filing notes that 342,395,697 shares of the issuer’s common stock were outstanding. Over the past three months, 10b5-1 sales for Adam Frankel included 500 shares sold on 12/11/2025 for $13,500.00, 1,000 shares on 12/10/2025 for $25,500.00, and 6,760 shares on 12/08/2025 for $161,174.62. By signing, the seller represents they are not aware of undisclosed material adverse information about the company.

FAQ

What does the CHYM Form 144 filing disclose about upcoming insider sales?

The filing discloses that Adam Frankel plans to sell 4,382 shares of CHYM common stock, with an aggregate market value of $119,321.86, through Morgan Stanley Smith Barney LLC on or around 01/08/2026 on the NASDAQ.

How were the 4,382 CHYM shares planned for sale originally acquired?

The 4,382 shares were acquired as restricted stock units from the issuer on 06/12/2025, with the same date listed as the date of payment and the nature of payment noted as N/A.

How many CHYM shares are outstanding according to this Form 144?

The Form 144 states that there are 342,395,697 shares of CHYM common stock outstanding, providing context for the planned sale relative to the total share count.

What recent 10b5-1 sales by Adam Frankel in CHYM stock are reported?

The document reports 10b5-1 sales for Adam Frankel of 500 shares on 12/11/2025 for $13,500.00, 1,000 shares on 12/10/2025 for $25,500.00, and 6,760 shares on 12/08/2025 for $161,174.62.

What representation does the seller make in the CHYM Form 144?

By signing the notice, the seller represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.

Which broker is handling the planned CHYM Form 144 sale?

The planned sale of 4,382 CHYM common shares is to be handled by Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/08/2026 - 04:21 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001241526
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Chime Financial, Inc.
SEC File Number	001-42693
Address of Issuer	101 California Street, Suite 500 San Francisco CALIFORNIA 94111
Phone	844-244-6363
Name of Person for Whose Account the Securities are To Be Sold	ADAM FRANKEL
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	4382	119321.86	342395697	01/08/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/12/2025	Restricted Stock Units	Issuer			4382	06/12/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for ADAM FRANKEL 101 California Street, Suite 500 San Francisco CA 94111	Common	12/11/2025	500	13500.00
10b5-1 Sales for ADAM FRANKEL 101 California Street, Suite 500 San Francisco CA 94111	Common	12/10/2025	1000	25500.00
10b5-1 Sales for ADAM FRANKEL 101 California Street, Suite 500 San Francisco CA 94111	Common	12/08/2025	6760	161174.62

144: Remarks and Signature

Remarks
Date of Notice	01/08/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	09/08/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Adam Frankel
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)